Bis-[4-alquil/aril-5-tia-1,2,4-triazóis] foram preparados pela fusão de diácidos e tiosemicarbazidas, pela condensação de hidrazidas ácidas aromáticas com isotiocianato. A alquilação quimiosseletiva destes bis-[4-alquil/aril-5-tia-1,2,4-triazóis] com 1, -dihaloalcanos na presença de hidróxido de potássio em metanol aquoso, proporcionou N-alquil/aril tiatriazolofanos inéditos.
Introduction
Crown compounds have generated considerable interest during the last three decades because of their ability to form stable complexes with a variety of metal and organic cations and anions. 1 They also have wide applications in phase transfer catalysis. 2 In recent years various structural changes have been made to the basic "crown ether" structure in order to enhance the selective activity of the ligands. 3 These changes involve the insertion of aromatic and/or heterocyclic ring systems into the macrocycles. Incorporation of heterocyclic subunit provides rigidity to the macrocycle and contributes in increasing the stability of complexes formed with both metals and organic cations. 3 The development of crown compounds especially macrocyclic compounds containing heterocyclic subunit has gained importance due to their wide range of applications. Several reviews and monographs have been published which highlight their synthesis and application in synthetic organic chemistry as phase transfer catalysts and in analytical chemistry as ligand for complexation. 2, 4 In recent years, attention has been increasingly paid to the synthesis of bisheterocyclic compounds, which exhibit various biological activities. 5 including antibacterial, antifungicidal, tuberculostatic and plant growth regulative properties. Bisheterocyclic compounds displayed much better antibacterial activity than heterocyclic compounds. 6 Various 1,2,4-triazoles are found to be associated with diverse pharmacological activities such as antiasthmatic, 7 antiviral (ribavirin), 8 antifungal (fluconazole), 9 antimicrobial, 10 antibacterial, 11 insecticidal, 11, 12 amoebicidal, 13 hypnotic, 14 cytotoxic, 15 and hypotensive 16 activities. This moiety was also found in potent agonist and antagonist receptor ligands, 17 in HIV-1 protease inhibitors 18 and in thrombin inhibitors. 19 Along with these significant pharmaceutical uses, 1,2,4-triazole derivatives are effectively used in polymers, dyestuff, photographic chemicals and agricultural chemicals. 20 We have previously reported the chemoselective synthesis of novel oxadiazolophanes 21 and N-aminotriazolophanes. 22 In continuation of this ongoing program in the synthesis of novel macrocyclic ligands 21, 22 their computational studies 21, 22 and their application as phase transfer catalyst (PTC), 22 we now report a facile chemoselective synthesis of novel N-alkyl/aryl thiatriazolophanes.
The present work describes a versatile synthetic strategy for the chemoselective synthesis of novel N-alkyl/aryl thiatriazolophanes. Obtained heterophanes would be similar to lariat ether 23 with N-alkyl/aryl groups as side arm. The study of the stereochemistry of these compounds is of interest as the two N-alkyl/aryl groups would be either cis or trans to each other depending on the alkyl chain joining the two heterocyclic units and the thermodynamic stability of the molecule.
There are many methods described in the literature for the synthesis of N-substituted-1,2,4-triazoles, 20 but none of them concerns the synthesis of heterophanes. Bis N-alkyl/ aryl thiatriazoles 3a-c were prepared in good yield by direct fusion of adipic acid 1 with thiosemicarbazides 2a-c, according to Xu method 24 (Scheme 1). This compound 3 containing thioamido groups has an amphoteric nature and can exist in tautomeric forms 3A and 3B. On alkylation of 3 with 1, -dihaloalkane, multiple products could form depending on the reactions conditions.
Reaction of compounds 3a-c with diiodoalkanes 4a-f in aq. methanol (80%) in the presence of potassium hydroxide as a base gave only products 5a-n chemoselectively in good yield (Scheme 1, Table 1 ). The reaction was carried out in large excess of solvent to ensure intramolecular cyclisation (high dilution condition).
The elucidation of structures 5a-n was accomplished on the basis of their spectral data and elemental analysis (Table 1) . For example, reaction of 3a with 1,2 diiodoethane 4b resulted in the formation of the desired N-ethylthiatriazolophane 5b, confirmed on the basis of NMR spectra.
1 H NMR spectrum of the compound showed triplet at 4.10 for S-CH 2 group of ethane chain. Absence of peak for C=S in 13 C NMR spectrum confirmed the chemoselectivity of S-alkylation. It showed signal for S-CH 2 carbon at 32.1 ppm. From the above data compound 5c was identified as 1 4 ,6 4 -diethyl-7,11-dithia-1,6(3,5)-di-(1,2,4-triazola)cycloundecaphane.
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The other thiatriazolophanes 5a-n were similarly synthesized and characterized.
In order to improve the solubility of the thiatriazolophanes, it was thought to incorporate a phenyl nucleus into the structure, which would also help in complexation by PTC. Hence, the scope of the previous reaction was extended to the synthesis of benzotriazolophanes 9 (Scheme 2). Bistriazoles 8 was synthesized in high yield, by reacting isophthalic acid dihydrazide 6 with phenyl/o-tolyl isothiocyanates 7.
The reaction of 8a-b with 4a-g in aqueous methanol (80%) in the presence of potassium hydroxide as a base gave desired benzotriazolophanes 9a-l chemoselectively in moderate yield (Scheme 2, Table 1 ). Structures of the products were confirmed on the basis of spectral data and elemental analysis (Table  1) . For example, reaction of 8a with 1,2-diiodoethane 4b resulted in the formation of desired benzotriazolophane 9a, confirmed on the basis of NMR spectra. To further explore the chelating properties of benzotriazolophanes, it was decided to incorporate "-O-" linkage in the heterophane skeleton. Hence, in continuation to this work on benzotriazolophanes, 3-carboxymethoxy phenoxyacetic acid 10 was fused with 4-ethyl thiosemicarbazide 2a to give compound 11 in high yield (Scheme 3). When 11 was reacted with 1,3-diiodopropane 4c in methanolic potassium hydroxide, compound 12c was afforded chemoselectively in moderate yield (Scheme 3, Table 1 ). Structure of the product was confirmed on the basis of spectral data and elemental analysis (Table 1) . 1 H NMR spectrum of the compound showed triplet at 3.62 for S-CH 2 group of propane chain and quintet at 3.02 for the central propyl -CH 2 . The other thiatriazolophanes 12a-f were similarly synthesized and characterized.
We have discussed in detail the chemoselective N-alkylation 22 and S-alkylation 21, 22 for the synthesis of triazolophanes. In continuation to our work on O-alkylation for the synthesis of heterophanes with amino side arms, 22 we now report the synthesis of novel N-substituted benzotriazolophanes. Salicylic acid hydrazide 13 was reacted with phenyl hydrazine, carbon disulphide and potassium hydroxide in methanol to give compound 14 in high yield (Scheme 4). When 14 was reacted with 1,3-diiodopropane in methanolic potassium hydroxide, compound 15 was afforded chemoselectively in good yield (Scheme 4, Table 1 ). Benzotriazolophanes 16a-c were subsequently synthesized in moderate yield by reacting 15 with diiodoalkanes in aqueous methanol (80%) containing potassium hydroxide (Scheme 4, Table  1 ). Structures of the products were confirmed on the basis of spectral data and elemental analysis (Table 1) . For example, reaction of 15 with 1,3-diiodopropane resulted in the formation of the desired compound 16a, which was confirmed on the basis of NMR spectra.
1 H NMR spectrum of the compound showed triplet at 3.62 for -SCH 2 group of propane chain and triplet at 4.18 for the propyl -OCH 2 groups. M + peak at m/z 648 in mass spectrum confirmed the formation of 16a.
Conclusion
In this paper, we have reported a versatile and convenient route for the synthesis of novel N-alkyl/aryl thiatriazolophanes from aliphatic and aromatic acids.
Experimental
The NMR spectra were recorded on Bruker AMX 500 spectrometer at 25 
Bis-(4-ethyl-5-mercapto-1,2,4-triazol-3-yl)butane (3a)
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Bis-(4-allyl-5-mercapto-1,2,4-triazol-3-yl)butane (3b)

General procedure for the synthesis of 5a-n, 8a-l, 12a-f, 15 and 16a-c
Compounds 3a-c, 7a-b, 11, 14 and 15 (respectively for the synthesis of 5a-n, 8a-l, 12a-f, 15 and 16a-c) (0.01 mol) were dissolved in aqueous methanol (80:20, methanol:water; 200 mL) containing potassium hydroxide (0.02 mol). A solution of 1, -dihaloalkane (0.01 mol) in methanol was added dropwise for an hour. This reaction mixture was then refluxed with stirring on a magnetic stirrer for eight hours. On cooling it to 10-15 o C, a solid separated out. This solid was then separated by filtration, washed with cold water and recrystallised from aqueous dimethyl formamide (DMF). 
